SANGAMO THERAPEUTICS INC (SGMO:NASDAQ)
$0.2512 -0.0107 (-4.0855%)
Analysed SANGAMO THERAPEUTICS INC (SGMO:NASDAQ) News Sources
Sangamo Therapeutics, Inc. Q4 2025 Earnings Call Summary
31-03-2026
moby.co
Sangamo Therapeutics Inc (SGMO) Q4 2025 Earnings Call Highlights: Strategic Advances and ...
31-03-2026
yahoo.com
Sangamo Therapeutics Q4 Earnings Call Highlights
31-03-2026
marketbeat.com
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
30-03-2026
yahoo.com
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates
26-03-2026
yahoo.com
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates
24-03-2026
yahoo.com
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call
19-03-2026
yahoo.com
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates
12-03-2026
yahoo.com
Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease
09-03-2026
yahoo.com
Should FDA Accelerated Approval Pathway for ST-920 Gene Therapy Data Require Action From Sangamo Therapeutics (SGMO) Investors?
04-02-2026
yahoo.com
What is the current price of SANGAMO THERAPEUTICS INC (SGMO:NASDAQ)?
The current price of SANGAMO THERAPEUTICS INC (SGMO:NASDAQ) is $0.2512.
SANGAMO THERAPEUTICS INC (SGMO:NASDAQ) absolute price change since previous trading day?
The absolute price change of SANGAMO THERAPEUTICS INC (SGMO:NASDAQ) since the previous trading day is $-0.0107.
SANGAMO THERAPEUTICS INC (SGMO:NASDAQ) percentage price change since previous trading day?
The percentage price change of SANGAMO THERAPEUTICS INC (SGMO:NASDAQ) since the previous trading day is -4.0855%.
What is the most recent average sentiment score for SANGAMO THERAPEUTICS INC (SGMO:NASDAQ)?
The most recent average sentiment score for SANGAMO THERAPEUTICS INC (SGMO:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for SANGAMO THERAPEUTICS INC (SGMO:NASDAQ)?
The most recent sentiment for SANGAMO THERAPEUTICS INC (SGMO:NASDAQ) is .
SEC-8K** Filing Available For SANGAMO THERAPEUTICS INC (SGMO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.